PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding PolyPid Ltd. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 13 | 15 | +2 |
| Shares | 2.54M | 2.89M | +347.3K (+13.6%) |
| Value | $6.90M | $10.2M | +$3.31M (+48.0%) |
New holders (4)
Institutions that held PolyPid Ltd. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Symmetry Peak Management LLC | 63,950 | $225.7K | 2.56% |
| Lumbard & Kellner, LLC | 38,200 | $134.8K | 0.06% |
| Northwestern Mutual Wealth Management Co | 3,968 | $14.0K | 0.00% |
| Raymond James Financial Inc | 65 | $229 | 0.00% |
Sold out (2)
Institutions that held PolyPid Ltd. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Stonepine Capital Management, LLC | 54,975 | $149.0K |
| Yelin Lapidot Holdings Management Ltd. | 11,153 | $30.2K |